Autoradiographic evidence for the effects of specific uptake-inhibitors on the selective accumulation of [3HJ-5-HT by supra-ependymal nerve terminals and for the localization of binding sites for [3H]-DLSD
暂无分享,去创建一个
[1] J. Richards,et al. Ultrastructural evidence for the localization of an indolealkylamine in supra-ependymal nerves from combined cytochemistry and pharmacology , 1974, Experientia.
[2] P. Riederer,et al. The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil , 2005, Journal of Neural Transmission.
[3] J. Richards,et al. 5-HT nerve terminals in the fourth ventricle of the rat brain: Their identification and distribution studied by fluorescence histochemistry and electron microscopy , 1975, Cell and Tissue Research.
[4] J. Richards,et al. Distribution of indolealkylamine nerve terminals in the ventricles of the rat brain , 1973, Zeitschrift für Zellforschung und Mikroskopische Anatomie.
[5] E. Neumayer,et al. Die moderne medikamentöse Behandlung des Parkinsonismus , 1972, Zeitschrift für Neurologie.
[6] I. Creese,et al. The dopamine receptor: differential binding of d-LSD and related agents to agonist and antagonist states. , 1975, Life sciences.
[7] S. Snyder,et al. Stereospecific binding ofd-lysergic acid diethylamide (LSD) to brain membranes: Relationship to serotonin receptors , 1975, Brain Research.
[8] J. Richards,et al. Indolealkylamine nerve terminals in cerebral ventricles: identification by electron microscopy and fluorescence histochemistry. , 1973, Brain research.
[9] D. Riddell,et al. A comparison of the pharmacological and biochemical properties of substrate‐selective monoamine oxidase inhibitors , 1972, British journal of pharmacology.
[10] M. Vogt,et al. Release of 5‐hydroxytryptamine from caudate nucleus and septum , 1972, The Journal of physiology.